Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology

Issue 13 - Minutes of Proceedings - March 29, 2012

OTTAWA, Thursday, March 29, 2012
(32)

[English]

The Standing Senate Committee on Social Affairs, Science and Technology met this day at 10:30 a.m., in room 2, Victoria Building, the chair, the Honourable Kelvin Kenneth Ogilvie, presiding.

Members of the committee present: The Honourable Senators Callbeck, Campbell, Demers, Eggleton, P.C., Merchant, Ogilvie, Seidman, Seth and Verner, P.C. (9).

In attendance: Sonya Norris and Karin Phillips, Analysts, Parliamentary Information and Research Service, Library of Parliament.

Also in attendance: The official reporters of the Senate.

Pursuant to the order of reference adopted by the Senate on Thursday, November 17, 2011, the committee continued its study on prescription pharmaceuticals in Canada. (For complete text of the order of reference, see proceedings of the committee, Issue No. 12.)

WITNESSES:

Canadian Institutes of Health Research:

Dr. Alain Beaudet, President.

Drug Safety and Effectiveness Network:

Dr. Robert Peterson, Executive Director.

Health Canada:

Barbara Sabourin, Director General, Helth Products and Food Banch, Therapeutic Products Directorate (TPD);

Dr. John Patrick Stewart, A/Director General, Clinical Trials Office, Therapeutic Products Directorate (TPD);

Kimby Barton, Director, Bureau of Cardiology, Allergy and Neurological Sciences, Therapeutic Products Directorate (TPD).

The chair made a statement.

Dr. Beaudet and Ms. Sabourin each made a statement and, together with Dr. Peterson, Dr. Stewart and Ms. Barton, answered questions.

At 12:26 p.m., the committee adjourned to the call of the chair.

ATTEST:

Jessica Richardson

Clerk of the Committee